stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Pacira BioSciences, Inc. (PCRX)
- Amphastar Pharmaceuticals, Inc. AMPH 27.59 −1.53%
- Pacira BioSciences, Inc. PCRX 36.44 +0.11%
Amphastar Pharmaceuticals, Inc. and Pacira BioSciences, Inc. are both Drug Manufacturers Specialty & Generic companies. Pacira BioSciences, Inc. is the larger, with a market value of $1.5B against $1.2B — 1.2× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 38.4×. Pacira BioSciences, Inc. grew revenue faster over the last twelve months: 3.70% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs 5.08%) and the higher return on invested capital (6.12% vs 5.37%). Across the 21 metrics below, Amphastar Pharmaceuticals, Inc. leads on 14 and Pacira BioSciences, Inc. on 7.
Valuation
Profitability
| Metric | AMPH | PCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 0.00% | 53.51% |
| Operating margin | 18.74% | 4.81% | 0.00% |
| Net margin | 13.27% | 5.08% | (2.45%) |
| Free cash flow margin | 18.64% | 22.74% | 0.00% |
| Return on equity | 12.44% | 5.24% | (0.80%) |
| Return on assets | 5.86% | 3.02% | (1.67%) |
| Return on invested capital | 6.12% | 5.37% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack